-+ 0.00%
-+ 0.00%
-+ 0.00%

NEURONOS GRANTED FDA ORPHAN DRUG DESIGNATION FOR GLIOBLASTOMA, THE MOST COMMON AND DEADLIEST PRIMARY MALIGNANT BRAIN CANCER IN ADULTS

Reuters·09/08/2025 12:00:02

Please log in to view news